Cart
sales@molnova.com
WAY-325398
CAS No. 445231-36-7
WAY-325398( —— )
Catalog No. M37671 CAS No. 445231-36-7
WAY-325398 is a furan derivatives. WAY-325398 inhibits osteoclast formation, inhibition rate is 14.11% at 10 μM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 263 | In Stock |
|
| 2MG | 166 | In Stock |
|
| 5MG | 255 | In Stock |
|
| 10MG | 375 | In Stock |
|
| 25MG | 562 | In Stock |
|
| 50MG | 770 | In Stock |
|
| 100MG | 1051 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2111 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameWAY-325398
-
NoteResearch use only, not for human use.
-
Brief DescriptionWAY-325398 is a furan derivatives. WAY-325398 inhibits osteoclast formation, inhibition rate is 14.11% at 10 μM.
-
DescriptionAnti-osteoporosis agent-6 (compound 174) is an anti-osteoporosis agent. Anti-osteoporosis agent-6 has 14.11% inhibition rate against osteoclast formation at 10 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number445231-36-7
-
Formula Weight357.79
-
Molecular FormulaC19H16ClNO4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC1=C(Cl)C=CC=C1)(=O)C=2OC(COC3=C(OC)C=CC=C3)=CC2
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jung-Keun Kim, et al. Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same. Patent, WO2004037804A1.
molnova catalog
related products
-
AMZ30
AMZ30 is a selective inhibitor of PME-1 (IC50: 600 nM). It also reduces the demethylated form of PP2A in living cells.
-
L-Aspartic acid
Aspartic Acid is a non-essential amino acid in humans, Aspartic Acid has an overall negative charge and plays an important role in the synthesis of other amino acids and in the citric acid and urea cycles.
-
Relatlimab
Relatlimab(BMS-986016) is a monoclonal antibody targeting human anti-LAG-3, generated by immunization of transgenic mice with human immunoglobulin carrying recombinant LAG-3 protein.
